These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: Peritoneal Dialysis for Patients with Autosomal Dominant Polycystic Kidney Disease.
    Author: Khan S, Giuliani A, Crepaldi C, Ronco C, Rosner MH.
    Journal: Perit Dial Int; 2017; 37(4):384-388. PubMed ID: 28676509.
    Abstract:
    End-stage renal disease secondary to autosomal dominant polycystic kidney (ADPKD) is a common issue worldwide. Peritoneal dialysis (PD) is a reasonable option for renal replacement therapy for these patients and should not be withheld due to concerns that the patient may not tolerate the fluid volumes in the peritoneal cavity. This review covers the existing data on the outcomes and complications associated with the use of PD in the polycystic kidney disease patient. In general, PD is well tolerated and outcomes in ADPKD patients are equivalent to or better than other patient groups.
    [Abstract] [Full Text] [Related] [New Search]